(2R,3R,4R,5R,8R,9S,10S,11R,12R)-5-ethyl-3,4-dihydroxy-11-[(3R,6R)-3-hydroxy-6-methyl-4-[methyl(propan-2-yl)amino]oxan-2-yl]oxy-9-[(4S,6S)-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2,4,8,10,12,14-hexamethyl-15-oxa-6-azabicyclo[10.2.1]pentadecan-7-one

C39H72N2O10 — CID 59903635

IUPAC(2R,3R,4R,5R,8R,9S,10S,11R,12R)-5-ethyl-3,4-dihydroxy-11-[(3R,6R)-3-hydroxy-6-methyl-4-[methyl(propan-2-yl)amino]oxan-2-yl]oxy-9-[(4S,6S)-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2,4,8,10,12,14-hexamethyl-15-oxa-6-azabicyclo[10.2.1]pentadecan-7-one
SMILESCC[C@H]1NC(=O)[C@H](C)[C@@H](OC2C[C@@](C)(OC)C[C@H](C)O2)[C@@H](C)[C@@H](OC2O[C@H](C)CC(N(C)C(C)C)[C@H]2O)[C@@]2(C)CC(C)C(O2)[C@H](C)[C@@H](O)[C@]1(C)O
InChIInChI=1S/C39H72N2O10/c1-15-28-39(12,45)33(43)24(7)31-21(4)17-38(11,51-31)34(50-36-30(42)27(16-22(5)48-36)41(13)20(2)3)25(8)32(26(9)35(44)40-28)49-29-19-37(10,46-14)18-23(6)47-29/h20-34,36,42-43,45H,15-19H2,1-14H3,(H,40,44)/t21?,22-,23+,24+,25-,26-,27?,28-,29?,30-,31?,32+,33-,34-,36?,37+,38-,39-/m1/s1
InChIKeyFUUJPDIZNDWKDN-CFHXUENVSA-N
MW729.01 g/mol
LogP4.00
Rot. Bonds8

About (2R,3R,4R,5R,8R,9S,10S,11R,12R)-5-ethyl-3,4-dihydroxy-11-[(3R,6R)-3-hydroxy-6-methyl-4-[methyl(propan-2-yl)amino]oxan-2-yl]oxy-9-[(4S,6S)-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2,4,8,10,12,14-hexamethyl-15-oxa-6-azabicyclo[10.2.1]pentadecan-7-one

(2R,3R,4R,5R,8R,9S,10S,11R,12R)-5-ethyl-3,4-dihydroxy-11-[(3R,6R)-3-hydroxy-6-methyl-4-[methyl(propan-2-yl)amino]oxan-2-yl]oxy-9-[(4S,6S)-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2,4,8,10,12,14-hexamethyl-15-oxa-6-azabicyclo[10.2.1]pentadecan-7-one (PubChem CID 59903635) has the molecular formula C39H72N2O10 and a molecular weight of 729.01 g/mol. Its IUPAC name is (2R,3R,4R,5R,8R,9S,10S,11R,12R)-5-ethyl-3,4-dihydroxy-11-[(3R,6R)-3-hydroxy-6-methyl-4-[methyl(propan-2-yl)amino]oxan-2-yl]oxy-9-[(4S,6S)-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2,4,8,10,12,14-hexamethyl-15-oxa-6-azabicyclo[10.2.1]pentadecan-7-one.

Molecular Properties

Compound Name(2R,3R,4R,5R,8R,9S,10S,11R,12R)-5-ethyl-3,4-dihydroxy-11-[(3R,6R)-3-hydroxy-6-methyl-4-[methyl(propan-2-yl)amino]oxan-2-yl]oxy-9-[(4S,6S)-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2,4,8,10,12,14-hexamethyl-15-oxa-6-azabicyclo[10.2.1]pentadecan-7-one
PubChem CID59903635
Molecular FormulaC39H72N2O10
Molecular Weight729.01 g/mol
Exact Mass728.52
IUPAC Name(2R,3R,4R,5R,8R,9S,10S,11R,12R)-5-ethyl-3,4-dihydroxy-11-[(3R,6R)-3-hydroxy-6-methyl-4-[methyl(propan-2-yl)amino]oxan-2-yl]oxy-9-[(4S,6S)-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2,4,8,10,12,14-hexamethyl-15-oxa-6-azabicyclo[10.2.1]pentadecan-7-one
SMILESCC[C@H]1NC(=O)[C@H](C)[C@@H](OC2C[C@@](C)(OC)C[C@H](C)O2)[C@@H](C)[C@@H](OC2O[C@H](C)CC(N(C)C(C)C)[C@H]2O)[C@@]2(C)CC(C)C(O2)[C@H](C)[C@@H](O)[C@]1(C)O
InChIInChI=1S/C39H72N2O10/c1-15-28-39(12,45)33(43)24(7)31-21(4)17-38(11,51-31)34(50-36-30(42)27(16-22(5)48-36)41(13)20(2)3)25(8)32(26(9)35(44)40-28)49-29-19-37(10,46-14)18-23(6)47-29/h20-34,36,42-43,45H,15-19H2,1-14H3,(H,40,44)/t21?,22-,23+,24+,25-,26-,27?,28-,29?,30-,31?,32+,33-,34-,36?,37+,38-,39-/m1/s1
InChIKeyFUUJPDIZNDWKDN-CFHXUENVSA-N
XLogP4.00
TPSA148.41 Ų
H-Bond Donors4
H-Bond Acceptors11
Rotatable Bonds8
Heavy Atoms51
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500729.01
LogP ≤ 54.00
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1011

Analyze (2R,3R,4R,5R,8R,9S,10S,11R,12R)-5-ethyl-3,4-dihydroxy-11-[(3R,6R)-3-hydroxy-6-methyl-4-[methyl(propan-2-yl)amino]oxan-2-yl]oxy-9-[(4S,6S)-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2,4,8,10,12,14-hexamethyl-15-oxa-6-azabicyclo[10.2.1]pentadecan-7-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2R,3R,4R,5R,8R,9S,10S,11R,12R)-5-ethyl-3,4-dihydroxy-11-[(3R,6R)-3-hydroxy-6-methyl-4-[methyl(propan-2-yl)amino]oxan-2-yl]oxy-9-[(4S,6S)-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2,4,8,10,12,14-hexamethyl-15-oxa-6-azabicyclo[10.2.1]pentadecan-7-one?
The IUPAC name of (2R,3R,4R,5R,8R,9S,10S,11R,12R)-5-ethyl-3,4-dihydroxy-11-[(3R,6R)-3-hydroxy-6-methyl-4-[methyl(propan-2-yl)amino]oxan-2-yl]oxy-9-[(4S,6S)-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2,4,8,10,12,14-hexamethyl-15-oxa-6-azabicyclo[10.2.1]pentadecan-7-one (CID 59903635) is (2R,3R,4R,5R,8R,9S,10S,11R,12R)-5-ethyl-3,4-dihydroxy-11-[(3R,6R)-3-hydroxy-6-methyl-4-[methyl(propan-2-yl)amino]oxan-2-yl]oxy-9-[(4S,6S)-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2,4,8,10,12,14-hexamethyl-15-oxa-6-azabicyclo[10.2.1]pentadecan-7-one.
What is the SMILES notation for (2R,3R,4R,5R,8R,9S,10S,11R,12R)-5-ethyl-3,4-dihydroxy-11-[(3R,6R)-3-hydroxy-6-methyl-4-[methyl(propan-2-yl)amino]oxan-2-yl]oxy-9-[(4S,6S)-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2,4,8,10,12,14-hexamethyl-15-oxa-6-azabicyclo[10.2.1]pentadecan-7-one?
The canonical SMILES for (2R,3R,4R,5R,8R,9S,10S,11R,12R)-5-ethyl-3,4-dihydroxy-11-[(3R,6R)-3-hydroxy-6-methyl-4-[methyl(propan-2-yl)amino]oxan-2-yl]oxy-9-[(4S,6S)-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2,4,8,10,12,14-hexamethyl-15-oxa-6-azabicyclo[10.2.1]pentadecan-7-one is CC[C@H]1NC(=O)[C@H](C)[C@@H](OC2C[C@@](C)(OC)C[C@H](C)O2)[C@@H](C)[C@@H](OC2O[C@H](C)CC(N(C)C(C)C)[C@H]2O)[C@@]2(C)CC(C)C(O2)[C@H](C)[C@@H](O)[C@]1(C)O.
What is the InChIKey of (2R,3R,4R,5R,8R,9S,10S,11R,12R)-5-ethyl-3,4-dihydroxy-11-[(3R,6R)-3-hydroxy-6-methyl-4-[methyl(propan-2-yl)amino]oxan-2-yl]oxy-9-[(4S,6S)-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2,4,8,10,12,14-hexamethyl-15-oxa-6-azabicyclo[10.2.1]pentadecan-7-one?
The InChIKey is FUUJPDIZNDWKDN-CFHXUENVSA-N. The full InChI is InChI=1S/C39H72N2O10/c1-15-28-39(12,45)33(43)24(7)31-21(4)17-38(11,51-31)34(50-36-30(42)27(16-22(5)48-36)41(13)20(2)3)25(8)32(26(9)35(44)40-28)49-29-19-37(10,46-14)18-23(6)47-29/h20-34,36,42-43,45H,15-19H2,1-14H3,(H,40,44)/t21?,22-,23+,24+,25-,26-,27?,28-,29?,30-,31?,32+,33-,34-,36?,37+,38-,39-/m1/s1.
What are the key properties of (2R,3R,4R,5R,8R,9S,10S,11R,12R)-5-ethyl-3,4-dihydroxy-11-[(3R,6R)-3-hydroxy-6-methyl-4-[methyl(propan-2-yl)amino]oxan-2-yl]oxy-9-[(4S,6S)-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2,4,8,10,12,14-hexamethyl-15-oxa-6-azabicyclo[10.2.1]pentadecan-7-one?
(2R,3R,4R,5R,8R,9S,10S,11R,12R)-5-ethyl-3,4-dihydroxy-11-[(3R,6R)-3-hydroxy-6-methyl-4-[methyl(propan-2-yl)amino]oxan-2-yl]oxy-9-[(4S,6S)-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2,4,8,10,12,14-hexamethyl-15-oxa-6-azabicyclo[10.2.1]pentadecan-7-one has a molecular weight of 729.01 g/mol, XLogP of 4.00, 8 rotatable bonds, 4 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for (2R,3R,4R,5R,8R,9S,10S,11R,12R)-5-ethyl-3,4-dihydroxy-11-[(3R,6R)-3-hydroxy-6-methyl-4-[methyl(propan-2-yl)amino]oxan-2-yl]oxy-9-[(4S,6S)-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2,4,8,10,12,14-hexamethyl-15-oxa-6-azabicyclo[10.2.1]pentadecan-7-one is sourced from PubChem (CID 59903635), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).